INTS8 is a therapeutic target for intrahepatic cholangiocarcinoma via the integration of bioinformatics analysis and experimental validation

Intrahepatic cholangiocarcinoma (CHOL) remains a rare malignancy, ranking as the leading lethal primary liver cancer worldwide. However, the biological functions of integrator complex subunit 8 (INTS8) in CHOL remain unknown. Thus, this research aimed to explore the potential role of INTS8 as a nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qi, Ji, Li, Shi, Xueying, Deng, Dawei, Guo, Fangyue, Wang, Zhengpeng, Liu, Wenhui, Zhang, Jinnan, Xia, Shilin, Shang, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654853/
https://www.ncbi.nlm.nih.gov/pubmed/34880328
http://dx.doi.org/10.1038/s41598-021-03017-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654853/
https://www.ncbi.nlm.nih.gov/pubmed/34880328
http://dx.doi.org/10.1038/s41598-021-03017-0

Ejemplares similares